Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial

Factors associated with surgical managem

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

✍ Criscitiello, C.; Azim, H. A.; Agbor-tarh, D.; de Azambuja, E.; Piccart, M.; Bas 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 96 KB

Use of luteinising-hormone-releasing hor

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 341 KB

Use of luteinising-hormone-releasing hor

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

✍ Fleming, G.F.; Francis, P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A phase II trial of letrozole in combina

A phase II trial of letrozole in combination with bevacizumab in patients with hormone receptor-positive metastatic breast cancer: Correlation of response with circulating endothelial (CEC) and epithelial cells (CTC)

✍ H. Rugo; Dickler; Y. Traina; J. Scott; D. Moore; E. Brogi; J. Bruckner; S. Flore 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Letter to the editor on 'Factors associa

Letter to the editor on 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial'

✍ Barry, P. A.; Schiavon, G.; MacNeill, F. A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 126 KB

Exemestane versus anastrozole as front-l

Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer : Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

✍ Antonio Llombart-Cussac; Amparo Ruiz; Antonio Antón; Agustí Barnadas; Silvia Ant 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views